The effect of prostaglandin analogues on central corneal thickness of patients with chronic open-angle glaucoma: A 2-year study on 129 eyes

Acta Ophthalmologica

Volumn 89, Issue 5, 2011, Pages 448-451

  Bafa, Maria ^a   Georgopoulos, Gerasimos ^b   Mihas, Constantinos ^a   Stavrakas, Panagiotis ^a   Papaconstantinou, Dimitrios ^b   Vergados, Ioannis ^b  

^a THRIASIO GENERAL HOSPITAL   (Greece)

^b University Ophthalmology Clinic   (Greece)

Author keywords

central corneal thickness; glaucoma; intraocular pressure; prostaglandins; ultrasound pachymetry

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; LATANOPROST; TRAVOPROST;

AGED; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; CORNEA THICKNESS; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMIDES; CLOPROSTENOL; CORNEA; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSTAGLANDINS F, SYNTHETIC; PROSTAGLANDINS, SYNTHETIC;

EID: 79960416966     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01731.x     Document Type: Article

References (26)

1. Alanco I, &, Airaksinen J, (1983): Effects of topical timolol on corneal endothelial cell morphology in vivo. Am J Ophthalmol 96: 615-621.
2. Beneyto P, &, Perez M, (1998): Effect of continued treatment with timolol maleate on corneal endothelium: a fluorophotometric study. Cornea 17: 600-603. (Pubitemid 28511904)
3. Damji K, &, Munger R, (2000): Influence of central corneal thickness on applanation intraocular pressure. J Glaucoma 9: 205-207. (Pubitemid 32429360)
4. Doughty M, &, Zaman M, (2000): Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol 44: 367-408. (Pubitemid 30151145)
5. Friedman LM, DeMets DL, &, Furberg CF, (1996): The randomization process. In: Fundamentals of Clinical Trials, 3rd edn. New York: Springer, 61-78.
6. Harasymowycz P, Papamatheakis D, Ennis M, Brady M, &, Gordon K, (2007): Relationship between Travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma. Cornea 26: 34-41. (Pubitemid 46041561)
7. Herndon L, Weizer J, &, Stinnett S, (2004): Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 122: 17-21. (Pubitemid 38063599)
8. Inoue K, Okugawa K, Kato S, Inoue Y, Tomita G, Oshika T, &, Amano S, (2003): Ocular factors relevant to antiglaucomatous eyedrop-related keratoepitheliopathy. J Glaucoma 12: 480-485. (Pubitemid 37494176)
9. Kaminski S, Hommer A, Koyuncu D, Biovski R, Barisani T, &, Baumgartner I, (1998): Influence of Dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. Acta Ophthalmol Scand 76: 78-79. (Pubitemid 28120603)
10. Kohlhas M, Boehm A, Spoerl E, Pursten A, Grein H, &, Pillunat L, (2006): Effect of corneal thickness, corneal curvature and axial length on applanation tonometry. Arch Ophthalmol 124: 471-476.
11. Lake S, Gullberg H, Wahlqvist J, et al., (1994): Cloning of the rat and human prostaglandin F2A receptors and the expression of the rat prostaglandin F2a receptor. FEBS Lett 355: 317-325.
12. Lass H, Khosrof A, Laurence K, et al., (1998): A double masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol and betaxolol. Arch Ophthalmol 116: 1003-1010.
13. Lass H, Eriksson L, Osterling L, et al., (2001): Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol and timolol. Ophthalmology 108: 264-271. (Pubitemid 32115954)
14. Liu Y, Yanai R, Lu W, Hirano S, Sagara T, &, Nishida T, (2006): Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts. J Glaucoma 15: 255-259.
15. Mietz H, Schlotzer-Schrebardt U, Strassfeld C, &, Krieglstain G, (2001): Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Invest Ophthalmol Vis Sci 42: 679-687. (Pubitemid 32206908)
16. Nesher R, Kass A, &, Gans A, (1990): Corneal endothelial changes in ocular hypertensive individuals after long-term unilateral treatment with timolol. Am J Ophthalmol 11: 309-310. (Pubitemid 20295202)
17. Pierce K, Fujino H, Srinivasan D, et al., (1999): Activation of FP prostanoid receptor isoforms leads to Rho-mediated changes in cell morphology and in the cell cytoskeleton. J Biol Chem 274: 35944-35949. (Pubitemid 129512903)
18. Sagara T, Gaton D, Lindsey J, Gabelt B, Kaufman P, &, Weinberg R, (1999): Topical prostaglandin F2a treatment reduces collagen types I, III and IV in the monkey uveoscleral outflow pathway. Arch Ophthalmol 117: 798-801.
19. Schachatchabel U, Lindsey J, &, Weinberg R, (2000): The mechanism of action of prostaglandins on uveoscleral outflow. Curr Opin Ophthalmol 11: 112-115. (Pubitemid 30164031)
20. Shah S, (2000): Accurate intraocular pressure measurement-the myth of modern ophthalmology. Ophthalmology 107: 1805-1807.
21. Shah S, Chatterjee A, Mathai M, et al., (1999): Relationship between central corneal thickness and measured intraocular pressure in general ophthalmology clinic. Ophthalmology 106: 2154-2160. (Pubitemid 30194239)
22. Shih C, Graff Zivin J, Trokel S, et al., (2004): Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol 122: 1270-1275. (Pubitemid 39180846)
23. Stodmeister R, (1998): Applanation tonometry and correction according to corneal thickness. Acta Ophthalmol Scand 76: 319-324.
24. Sugimoto Y, Hasumoto K, Namba T, et al., (1999): Cloning and expression of a c DNA for a mouse prostaglandin F receptor. J Biol Chem 274: 35944-35949.
25. 2a- analogues and carbonic anhydrase inhibitors on central corneal thickness-a cross sectional study on 403 eyes. Klin Monatsbl Augenhelkd 221: 753-756. (Pubitemid 39390855)
26. Wu K-Y, Wang H-Z, &, Hong S-J, (2005): Effect of latanoprost on cultured porcine stromal cells. Curr Eye Res 30: 871-879. (Pubitemid 43154705)